Tower Research Capital LLC (Trc) Kinnate Biopharma Inc. Transaction History

Tower Research Capital LLC (Trc)

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.24 - $2.66 $21,380 - $25,389	-9,545 Reduced 89.74%	1,091 $2,000
Q4 2023 Feb 13, 2024	SELL	$1.07 - $2.5 $74 - $175	-70 Reduced 0.65%	10,636 $25,000
Q3 2023 Nov 14, 2023	SELL	$1.38 - $3.31 $1,119 - $2,684	-811 Reduced 7.04%	10,706 $14,000
Q2 2023 Aug 14, 2023	BUY	$2.33 - $6.84 $19,625 - $57,613	8,423 Added 272.24%	11,517 $34,000
Q1 2023 May 09, 2023	BUY	$3.46 - $7.98 $8,324 - $19,199	2,406 Added 349.71%	3,094 $20,000
Q4 2022 Feb 10, 2023	SELL	$5.26 - $12.19 $32,811 - $76,041	-6,238 Reduced 90.07%	688 $4,000
Q3 2022 Nov 10, 2022	BUY	$9.86 - $15.76 $49,507 - $79,130	5,021 Added 263.57%	6,926 $83,000
Q2 2022 Aug 15, 2022	BUY	$7.43 - $13.0 $8,299 - $14,521	1,117 Added 141.75%	1,905 $24,000
Q1 2022 May 12, 2022	SELL	$7.73 - $17.99 $4,212 - $9,804	-545 Reduced 40.89%	788 $9,000
Q4 2021 Feb 14, 2022	BUY	$16.5 - $25.48 $13,216 - $20,409	801 Added 150.56%	1,333 $23,000
Q3 2021 Nov 15, 2021	SELL	$17.81 - $24.87 $2,065 - $2,884	-116 Reduced 17.9%	532 $12,000
Q2 2021 Aug 16, 2021	SELL	$22.19 - $31.55 $44 - $63	-2 Reduced 0.31%	648 $15,000
Q1 2021 May 17, 2021	BUY	$26.99 - $40.0 $17,543 - $26,000	650 New	650 $20,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.